Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05102864 · ClinicalTrials.gov registry record · NA

A Trial of Two-Week Brain Stimulation for Teenagers With ADHD

A NA study of ADHD, sponsored by Bradley Hospital.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05102864: Active NA study of ADHD, sponsored by Bradley Hospital.

NCT05102864 is a NA study of ADHD that is active but no longer recruiting, run by Bradley Hospital. The registered enrollment target is 25 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05102864, a NA study of ADHD, is active but no longer recruiting, sponsored by Bradley Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The objective of this clinical trial is to examine whether non-invasive brain stimulation can modulate dysfunctional brain dynamics underlying adolescent ADHD to subsequently improve clinical symptoms.

Primary Outcome

EEG recording will be obtained while the participant completes the Sternberg Spatial Working Memory Test (SWMT). The coupling between theta phase and gamma amplitude will be extracted from the EEG during encoding and maintaining demands.

Conditions Studied

Interventions

  • DEVICE Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex

Study Locations (1)

Rhode Island

  • E. P. Bradley Hospital - East Providence

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-10-01
Est. Completion 2026-10-01
Phase NA
Bradley Hospital

12 total trials

What the registry record for NCT05102864 still lists

NCT05102864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (87% lower).

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex is the first listed.

NCT05102864 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05102864 about?

NCT05102864 is a clinical study titled "A Trial of Two-Week Brain Stimulation for Teenagers With ADHD". The objective of this clinical trial is to examine whether non-invasive brain stimulation can modulate dysfunctional brain dynamics underlying adolescent ADHD to subsequently improve clinical symptoms.

What is the current status of trial NCT05102864?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-10-01. Estimated completion is 2026-10-01.

What conditions does trial NCT05102864 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT05102864?

The interventions under investigation include: Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex (DEVICE).

Who is sponsoring clinical trial NCT05102864?

This trial is sponsored by Bradley Hospital, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05102864 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05102864's enrollment target sits among peer trials

25 67th of 75 higher than 9 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05102864, the US trial registry maintained by the National Library of Medicine. NCT05102864 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.